Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5824309 | 0.84 | TSHR (0.43) | TSHRMEN1KMT2ALMNAADRA1A | |
| SCHEMBL17191649 | 0.84 | TSHR (0.32) | TSHRMEN1KMT2AMAPT | |
| SCHEMBL15685105 | 0.84 | TSHR (0.32) | TSHRMEN1KMT2AMAPT | |
| SCHEMBL9901276 | 0.84 | TSHR (0.32) | TSHRMEN1KMT2A | |
| SCHEMBL1254813 | 0.82 | ELANE (0.31) | TSHR | |
| SCHEMBL9678131 | 0.81 | TSHR (0.46) | TSHRMEN1KMT2ALMNAADRA1A | |
| SCHEMBL28890230 | 0.81 | TSHR (0.46) | TSHRMEN1KMT2ALMNAADRA1A | |
| SCHEMBL25258063 | 0.80 | MEN1 (0.32) | TSHRMEN1KMT2ALMNAADRA1A | |
| SCHEMBL20561810 | 0.80 | — | — | |
| SCHEMBL6063978 | 0.78 | TSHR (0.48) | TSHRMEN1KMT2ALMNAADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | claimed |
| EP-4568953-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2025-06-18 | — | — | EP | claimed |
| CN-119894883-A | Methods and processes for preparing MCT4 inhibitors | 维托尔股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-118813080-A | Metal-based anticorrosive paint and preparation method and application thereof | 国科先材(合肥)科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| WO-2024031445-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2024-02-15 | — | — | WO | claimed |
| CN-116622039-B | Vinyl pyrrolidone segmented copolymer and preparation method and application thereof | 上海宇昂水性新材料科技股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116589636-B | Silver nanowire end capping agent and preparation method and application thereof | 上海宇昂水性新材料科技股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116589636-A | Silver nanowire end capping agent and preparation method and application thereof | 上海宇昂水性新材料科技股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-116554014-A | Preparation method of fenofibrate and impurities thereof | 浙江恒康药业股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116082145-A | Fibrate derivative with antioxidant activity, synthesis method and application thereof | 天津科技大学 | 2023-05-09 | — | — | CN | claimed |
| CN-113185469-B | Method for modifying photoregulated diaryl dihydrophenazine | 南京先进生物材料与过程装备研究院有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-113185469-A | Method for modifying photoregulated diaryl dihydrophenazine | 南京先进生物材料与过程装备研究院有限公司 | 2021-07-30 | — | — | CN | claimed |
| EP-0582441-A1 | Processes for the preparation of tyramine derivatives | CHEMAGIS LTD. (IL) | 1994-02-09 | — | — | EP | claimed |
| CN-116554014-B | Preparation method of fenofibrate and impurities thereof | 浙江恒康药业股份有限公司 | 2025-12-23 | — | — | CN | disclosed |
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | disclosed |
| EP-4568667-A2 | SALTS OF HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTER 4 FOR THE TREATMENT OF DISEASE | Vettore, LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2005039596-A1 | SILYL PHENOLS FOR PROMOTING VASCULAR HEALTH | AMYLIN PHARMACEUTICALS, INC. (US) | 2005-05-06 | — | — | WO | disclosed |
| US-20040073058-A1 | Process for the preparation of fibrates | OLON S.P.A. (IT) | 2004-04-15 | — | — | US | disclosed |
| EP-0582441-A1 | Processes for the preparation of tyramine derivatives | CHEMAGIS LTD. (IL) | 1994-02-09 | — | — | EP | disclosed |
| US-4739101-A | Method for the preparation of fibrates | FOURNIER INNOVATION ET SYNERGIE (FR) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073058-A1 | Process for the preparation of fibrates | CPT1A, CES1, CPT1B | TSHR 1616/4885MEN1 4105/4885KMT2A 2168/4885 |
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | SLC16A3, SLC16A1, SLC16A8 | TSHR 2573/4885MEN1 524/4885KMT2A 1539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.